Review Articles
Vol. 16 No. 1 (2024): Review Articles, Original Article, Scientific Letter, Case Reports Letter to the Editor

PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW

Pediatric Hodgkin's lymphoma in low-income countries

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: September 17, 2024
Accepted: October 2, 2024
Published: October 31, 2024
1230
Views
703
Downloads
177
HTML

Authors

Pediatric Hodgkin lymphoma (HL) is a curable disease for more than 90% of children and adolescents in high income countries. However, similar results cannot be achieved, particularly for advanced disease, in low- and middle-income countries (LMICs), where challenging socioeconomic realities and the consequent scarcity of local resources heavily impact on the treatment and patients’ outcome. Information regarding the management and outcome of pediatric HL in LMICs is still limited. In this narrative review, we summarize the results reported in the literature so far and discuss the critical key points that have emerged from this overview.

Downloads

Download data is not yet available.

Citations

How to Cite



“PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW: Pediatric Hodgkin’s lymphoma in low-income countries” (2024) Mediterranean Journal of Hematology and Infectious Diseases, 16(1), p. e2024078. doi:10.4084/MJHID.2024.078.